SCOTTSDALE, AZ--(Marketwired - Aug 2, 2013) - Hope Pharmaceuticals today announced that the United States Patent and Trademark Office issued U. S. patent no. 8,496,973, titled "Sodium ...

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. DBL Sodium Thiosulfate Injection contains the active ingredient sodium ...

Cisplatin chemotherapy and surgery are effective treatments for children with standard-risk hepatoblastoma but may cause considerable and irreversible hearing loss. This trial compared cisplatin with ...

Credit: Getty Images. The approval was based on data from 2 pivotal phase 3 trials, which evaluated Pedmark in pediatric patients undergoing treatment with cisplatin-based chemotherapy. The Food and ...

Prognostic and Predictive Value of Immunoscore in Stage III Colorectal Cancer: Pooled Analysis of Cases From the SCOT and IDEA-HORG Studies Thirty-one articles were summarized. Overall, systemic STS ...

Please provide your email address to receive an email when new articles are posted on . WASHINGTON — Sodium thiosulfate, administered before and after reperfusion for STEMI, did not improve infarct ...

Sodium thiosulfate appeared associated with a decreased risk for ototoxic effects when administered during platinum-based chemotherapy, according to results of a study published in JAMA Network Open.

Prognostic and Predictive Value of Immunoscore in Stage III Colorectal Cancer: Pooled Analysis of Cases From the SCOT and IDEA-HORG Studies Hearing loss occurs in 50%-70% of children treated with ...